Gilead data suggests once-yearly shot of PrEP drug blocks HIV infection
Last year, Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with just a single injection every six months. The drug, now…
Last year, Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with just a single injection every six months. The drug, now under regulatory review, was greeted as a breakthrough, the closest thing the field has ever had to a vaccine.
On Tuesday, Gilead published early data suggesting a new formulation of the drug could be used to prevent infection with just a single shot every year.
